Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Current Assets (2021 - 2025)

Universe Pharmaceuticals' Current Assets history spans 5 years, with the latest figure at $53.6 billion for Q3 2025.

  • For Q3 2025, Current Assets rose 103707.08% year-over-year to $53.6 billion; the TTM value through Sep 2025 reached $53.6 billion, up 103707.08%, while the annual FY2025 figure was $53.6 billion, 103707.08% up from the prior year.
  • Current Assets for Q3 2025 was $53.6 billion at Universe Pharmaceuticals, up from $51.6 million in the prior quarter.
  • Across five years, Current Assets topped out at $53.6 billion in Q3 2025 and bottomed at $25.3 million in Q3 2023.
  • The 5-year median for Current Assets is $50.5 million (2021), against an average of $10.8 billion.
  • The largest annual shift saw Current Assets crashed 39.12% in 2023 before it surged 103707.08% in 2025.
  • A 5-year view of Current Assets shows it stood at $50.5 million in 2021, then dropped by 17.78% to $41.5 million in 2022, then plummeted by 39.12% to $25.3 million in 2023, then soared by 104.35% to $51.6 million in 2024, then soared by 103707.08% to $53.6 billion in 2025.
  • Per Business Quant, the three most recent readings for UPC's Current Assets are $53.6 billion (Q3 2025), $51.6 million (Q3 2024), and $25.3 million (Q3 2023).